Navigation

List of technologies with approved Patient Access Schemes, recommended by NICE for use in the NHS.

TA Ref Treatment Indication Company Type
TA185 Trabectedin (Yondelis) Advanced soft tissue sarcoma PharmaMar Dose cap
TA155 Ranibizumab (Lucentis) Macular degeneration (Acute wet AMD) Novartis Simple discount
TA171 Lenalidomide (Revlimid) Multiple myeloma Celgene Dose cap
TA162 Erlotinib (Tarceva) Non small cell lung cancer Roche Simple discount
TA129 Bortezomib (Velcade) Multiple myeloma JC Response scheme
TA180 Ustekinumab (Stelera) Moderate to severe psoriasis J&J / JC Free stock
TA179 Sunitinib (Sutent) Gastrointestinal stromal tumour Pfizer Free stock
TA176 Cetuximab (Erbitux) Metastatic colorectal cancer (first Line) Merck S. Rebate
TA169 Sunitinib (Sutent) Renal cell carcinoma Pfizer Free stock
TA186 Certolizumab pegol (Cimzia) Rheumatoid arthritis UCB Free initial stock
TA192 Gefitinib (Iressa) Non small cell lung cancer Astra Zeneca Single fixed price
TA215 Pazopanib (Votrient) Advanced renal cell carcinoma GSK Discount+ poss rebate
TA218 Azacitidine (Vidaza) Myelodysplastic syndromes, chronic myelomonocytic leukaemia and acute myeloid leukaemia Celgene Simple discount
TA220 Golimumab (Simponi) Psoriatic arthritis Merck Sharp & Dohme Free stock
TA221 Romiplostim (Nplate) Chronic idiopathic (immune) thrombocytopenic purpura Amgen Simple discount
TA225 Golimumab (Simponi) Rheumatoid arthritis Merck Sharp & Dohme Free stock
TA233 Golimumab (Simponi) Ankylosing spondylitis Merck Sharp & Dohme Free stock
TA235 Mifamurtide (Mepact) High grade resectable non-metastatic osteosarcoma Takeda Simple discount
TA238 Tocilizumab (RoActemra) Systemic juvenile idiopathic arthritis Roche Simple discount
TA241 Nilotinib (Tasigna) Imatinib-resistant chronic myeloid leukaemia Novartis Simple discount
TA247 Tocilizumab (RoActemra) Rheumatoid arthritis Roche Simple discount
TA251 Nilotinib (Tasigna) First-line treatment of chronic myeloid leukaemia Novartis Simple discount
TA254 Fingolimod (Gilenya) Highly active relapsing-remitting multiple sclerosis Novartis Simple discount
TA258 Erlotinib (Tarceva) First-line treatment of locally advanced or metastatic EGFR-TK mutation-positive non-small-cell lung cancer Roche Simple discount
TA259 Abiraterone acetate (Zytiga) Castration-resistant metastatic prostate cancer previously treated with a docetaxel containing regimen Janssen-Cilag Simple discount
TA265 Denosumab (Xgeva) Skeletal related events in adults with bone metastases from solid tumours Amgen Simple discount
TA268 Ipilimumab (Yervoy) Advanced melanoma, 2nd Line Bristol-Myers Squibb Simple discount
TA269 Vemurafenib (Zelboraf) Metastatic mutation positive melanoma Roche Simple discount
TA274 Ranibizumab (Lucentis) Diabetic macular odema Novartis Simple discount
TA276 Colistimethate (Colobreathe) Pseudomonas aeruginosa for adults and children over 6 with cystic fibrosis Forest Laboratories UK Simple Discount
TA276 Tobramycin (TOBI Podhaler) Pseudomonas aeruginosa for adults and children over 6 with cystic fibrosis Novartis Simple Discount
TA278 Omalizumab (Xolair) Severe persistant asthma Novartis Simple Discount
TA280 Abatacept (Orencia) Rheumatoid arthritis, polyarticular juvenile idiopathic arthritis Bristol-Myers Squibb Simple Discount
TA282 Pirfenidone (Esbriet) Mild to moderate idiopathic pulmonary fibrosis Intermune Simple Discount
TA283 Ranibizumab (Lucentis) Macular oedema secondary to retinal vein occlusion Novartis Simple Discount
TA293 Eltrombopag (Revolade) Chronic immune (idiopathic) thrombocytopenic purpura GSK

Simple

Discount

TA294 Aflibercept (Eylea) Wet age‑related macular degeneration Bayer

Simple

Discount

TA298 Ranibizumab (Lucentis) Choroidal neovascularisation secondary to pathologic myopia Novartis Simple Discount
TA301 Fluocinolone (Iluvien) Diabetic macula oedema Alimera Sciences Simple Discount
TA303 Teriflunomide (Aubagio) Active relapsing-remitting multiple sclerosis Genzyme Simple Discount
TA305 Aflibercept (Eylea) Visual impairment caused by macular oedema secondary to central retinal vein occlusion Bayer Simple Discount
TA306 Pixantrone (Pixuvri) Multiple relapsed or refractory aggressive non-Hodgkin's B-cell lymphoma CTI Life Sciences Simple Discount

This page was last updated: 24 March 2014

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.